Develops engineered biologics that trigger targeted immune activation in diseased tissue for safer, more precise therapies.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Geneos Therapeutics engineers novel immune‑activating biologics designed to precisely control immune responses for cancer and autoimmune conditions. The company’s platform focuses on conditionally active molecules that activate immune pathways only within diseased environments to enhance effectiveness while reducing off‑target toxicity. Its work aims to expand safe, targeted immune therapies by combining deep biology insights with engineered specificity.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Geneos Therapeutics Valuations & Financials
View real-time NPM data on Geneos Therapeutics stock including daily Geneos Therapeutics stock price estimates, valuation history, and historical share price information. Access Geneos Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Geneos Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Geneos Therapeutics? Get in touch to learn more.
Similar Companies
like Geneos Therapeutics
Hinge Health
Healthcare & Life Sciences
Digital clinic for back, joint, and muscle pain.
Cerebral
Healthcare & Life Sciences
Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.
Eikon Therapeutics
Healthcare & Life Sciences
Uses revolutionary technology to discover novel treatments for life-threatening diseases.
Cedar
Healthcare & Life Sciences
The tech platform uses modern intelligence to improve healthcare financial experiences for everyone.
Resilience
Healthcare & Life Sciences
Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.
Elligo Health Research
Healthcare & Life Sciences
Connects healthcare sites, sponsors, and patients to streamline clinical trial access through technology and data-driven solutions.
Virta Health
Healthcare & Life Sciences
Online specialty medical clinic focused on reversing type 2 diabetes.
Droplet Biosciences
Healthcare & Life Sciences
Turning surgical drain fluid into powerful, early molecular insights to guide personalized post-surgery cancer care.
FAQ
We have answers
Geneos Therapeutics stock does not trade on public stock exchanges. Geneos Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Geneos Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Geneos Therapeutics Stock does not trade on public stock exchanges. In order to sell Geneos Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Geneos Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Geneos Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Geneos Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Geneos Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Geneos Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Geneos Therapeutics is a private company and has not had an IPO. There is currently no Geneos Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Geneos Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
